We studied the expanded CAG repeat and adjacent CCG repeat in 53 Huntington’s disease (HD) patients and 172 unrelated normal subjects matched to the patients for ethnic origin. The range of the CAG repeat varied from 38 to 109 in the HD patients and from 10 to 29 in the control group. A significant negative correlation was found between the age at onset and the CAG expansion, with no significant influence of the adjacent CCG repeat on the age at onset by multiple regression analysis. Allelic association using CCG repeat and 2 flanking dinucleotide repeat markers within 150 kb of the HD gene revealed linkage disequilibrium for 2 of 3 markers. Haplotype analysis of 24 HD families using these markers identified 3 major haplotypes underlying 87.5% of HD chromosomes. The data suggested frequent haplotypes in the Taiwanese population on which one or more mutational events leading to the disease occurred.

1.
Harper PS: Huntington’s Disease. London, WB Saunders, 1991.
2.
The Huntington’s Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993;72:971–983.
3.
Rubinsztein DC, Barton DE, Davison BCC, Ferguson-Smith MA: Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington’s disease and CAG repeat number. Hum Mol Genet 1993;2:1713–1715.
4.
Andrew SE, Goldberg YP, Theilmann J, Zeisler J, Hayden MR: A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: Implications for diagnostic accuracy and predictive testing. Hum Mol Genet 1994;3:65–67.
5.
Barron LH, Rae A, Holloway S, Brock DJ, Warner JP: A single allele from the polymorphic CCG-rich sequence immediately 3′ to the unstable CAG trinucleotide in the IT15 cDNA shows almost complete disequilibrium with Huntington’s disease chromosomes in the Scottish population. Hum Mol Genet 1994;3:173–175.
6.
Novelletto A, Persichetti F, Sabbadini G, Mandich P, Bellone E, Ajmar F, Squitieri F, Campanella G, Bozza A, MacDonald ME, Gusella JF, Frontali M: Polymorphism analysis of the huntingtin gene in Italian families affected with Huntington disease. Hum Mol Genet 1994;3:1129–1132.
7.
Masuda N, Goto J, Murayama N, Watanabe M, Kondo I, Kanazawa I: Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington’s disease. J Med Genet 1995;32:701–705.
8.
Pramanik S, Basu P, Gangopadhaya PK, Sinha KK, Jha DK, Sinha S, Das SK, Maity BK, Mukherjee SC, Roychoudhuri S, Majumder PP, Bhattacharyya NP: Analysis of CAG and CCG repeats in Huntington gene among HD patients and normal populations of India. Eur J Hum Genet 2000;8:678–682.
9.
Rubinsztein DC, Leggo J, Chiano M, Dodge A, Norbury G, Rosser E, Craufurd D: Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci USA 1997;94:3872–3876.
10.
Britton JW, Uitti RJ, Ahlskog JE, Robinson RG, Kremer B, Hayden MR: Hereditary late-onset chorea without significant dementia. Genetic evidence for substantial phenotypic variant in HD. Neurology 1995;45:443–447.
11.
Racette BA, Perlmutter JS: Levodopa responsive parkinsonism in an adult with Huntington’s disease. J Neurol Neurosurg Psychiatry 1998;65:577–579.
12.
Reuter I, Hu MT, Andrews TC, Brooks DJ, Clough C, Chaudhuri KR: Late onset levodopa responsive Huntington’s disease with minimal chorea masquerading as Parkinson plus syndrome. J Neurol Neurosurg Psychiatry 2000;68:238–241.
13.
Leung CM, Chan YW, Chang CM, Yu YL, Chen CN: Huntington’s disease in Chinese: a hypothesis of its origin. J Neurol Neurosurg Psychiatry 1992;55:681–684.
14.
Squitieri F, Andrew SE, Goldberg YP, Kremer B, Spence N, Zeisler J, Nichol K, Theilmann J, Greenberg J, Goto J, Kanazawa I, Vesa J, Peltonen L, Almqvist E, Anvret M, Telenius H, Lin B, Napolitano G, Morgan K, Hayden MR: DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum Mol Genet 1994;3:2103–2114.
15.
Zeng YT, Mao YH, Chen MJ, Ren ZR, Zhou G, Sheng M, Wang XY, Xu ZD, Yie WH, Zhao XZ, He X, Huang SZ: Molecular analysis of the Huntington’s disease with expanded CAG trinucleotide repeat in Chinese. J Genet Mol Biol 1996;7:1–6.
16.
Chattopadhyay B, Ghosh S, Gangopadhyay PK, Das SK, Roy T, Sinha KK, Jha DK, Mukherjee SC, Chakraborty A, Singhal BS, Bhattacharya AK, Bhattacharyya NP: Modulation of age at onset in Huntington’s disease and spinocerebellar ataxia type 2 patients originated from eastern India. Neurosci Lett 2003;345:93–96.
17.
Vuillaume I, Vermersch P, Destee A, Petit H, Sablonnière B: Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington’s disease. J Neurol Neurosurg Psychiatry 1998;64:758–762.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.